Changmao Biochemical Engineering Company Limited
HKEX:0954.HK
0.46 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 637.078 | 730.034 | 547.976 | 444.106 | 494.58 | 639.12 | 630.841 | 594.402 | 514.779 | 561.669 | 703.032 | 653.218 | 620.233 | 515.574 | 385.302 | 418.426 | 397.42 | 321.44 | 93.042 | 95.228 | 89.321 |
Cost of Revenue
| 611.269 | 549.203 | 509.296 | 341.065 | 359.425 | 509.394 | 555.846 | 488.87 | 399.949 | 450.34 | 534.023 | 525.765 | 506.045 | 378.212 | 295.961 | 328.423 | 319.555 | 217.228 | 16.631 | 17.022 | 12.344 |
Gross Profit
| 25.809 | 180.831 | 38.68 | 103.041 | 135.155 | 129.726 | 74.995 | 105.532 | 114.83 | 111.329 | 169.009 | 127.453 | 114.188 | 137.362 | 89.341 | 90.003 | 77.865 | 104.212 | 76.411 | 78.206 | 76.977 |
Gross Profit Ratio
| 0.041 | 0.248 | 0.071 | 0.232 | 0.273 | 0.203 | 0.119 | 0.178 | 0.223 | 0.198 | 0.24 | 0.195 | 0.184 | 0.266 | 0.232 | 0.215 | 0.196 | 0.324 | 0.821 | 0.821 | 0.862 |
Reseach & Development Expenses
| 10.209 | 13.92 | 12.649 | 11.591 | 10.302 | 8.677 | 8.117 | 8.036 | 7.53 | 8.485 | 16.005 | 13.674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 74.618 | 88.545 | 73.486 | 70.888 | 60.961 | 63.554 | 62.211 | 61.956 | 59.615 | 58.965 | 69.109 | 61.355 | 52.395 | 49.325 | 38.97 | 26.039 | 23.264 | 23.884 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 8.689 | 8.421 | 8.21 | 13.932 | 14.064 | 15.169 | 18.464 | 17.96 | 15.096 | 14.196 | 15.348 | 16.247 | 12.731 | 10.028 | 8.127 | 7.644 | 7.105 | 7.015 | 0 | 0 | 0 |
SG&A
| 83.307 | 96.966 | 81.696 | 84.82 | 75.025 | 78.723 | 80.675 | 79.916 | 74.711 | 73.161 | 84.457 | 77.602 | 65.126 | 59.353 | 47.097 | 33.683 | 30.369 | 30.899 | 0 | 0 | 0 |
Other Expenses
| 0 | -3.477 | -4.664 | -2.853 | -3.746 | 2.357 | 2.423 | 1.362 | 1.155 | 0.883 | 0.207 | 0.474 | -5.4 | -5.02 | -10.778 | -1.792 | -2.779 | -4.766 | 33.32 | 22.435 | 38.645 |
Operating Expenses
| 76.562 | 93.489 | 77.032 | 81.967 | 71.279 | 76.009 | 67.891 | 76.78 | 71.646 | 66.218 | 82.669 | 72.568 | 59.726 | 54.333 | 36.319 | 31.891 | 27.59 | 26.133 | 33.32 | 22.435 | 38.645 |
Operating Income
| -52.048 | 89.373 | -38.352 | 16.999 | 62.81 | 55.454 | 1.215 | 34.437 | 50.32 | 45.067 | 88.561 | 69.06 | 54.462 | 83.029 | 53.022 | 58.112 | 50.384 | 79.687 | 44.426 | 57.138 | 41.805 |
Operating Income Ratio
| -0.082 | 0.122 | -0.07 | 0.038 | 0.127 | 0.087 | 0.002 | 0.058 | 0.098 | 0.08 | 0.126 | 0.106 | 0.088 | 0.161 | 0.138 | 0.139 | 0.127 | 0.248 | 0.477 | 0.6 | 0.468 |
Total Other Income Expenses Net
| -80.193 | -1.729 | 122.761 | 0.153 | -0.257 | -0.853 | -3.088 | 0.364 | 0.687 | -3.152 | -6.958 | -9.735 | -8.01 | 3.965 | -3.081 | -9.065 | -9.688 | -5.342 | -3.243 | -3.319 | -2.744 |
Income Before Tax
| -58.58 | 87.644 | 84.409 | 17.152 | 62.553 | 54.601 | 1.244 | 34.801 | 51.007 | 41.915 | 81.603 | 59.325 | 46.452 | 86.994 | 49.941 | 49.047 | 40.696 | 74.345 | 41.184 | 53.82 | 39.061 |
Income Before Tax Ratio
| -0.092 | 0.12 | 0.154 | 0.039 | 0.126 | 0.085 | 0.002 | 0.059 | 0.099 | 0.075 | 0.116 | 0.091 | 0.075 | 0.169 | 0.13 | 0.117 | 0.102 | 0.231 | 0.443 | 0.565 | 0.437 |
Income Tax Expense
| 27.938 | 6.286 | 26.202 | 0.409 | 4.626 | 4.692 | -1.456 | 1.485 | 5.861 | 4.497 | 11.275 | 9.757 | 4.749 | 11.135 | 7.074 | 3.413 | 6.078 | 6.987 | 6.21 | 7.294 | 3.634 |
Net Income
| -86.057 | 81.423 | 58.318 | 16.827 | 58.299 | 50.525 | 3.382 | 33.172 | 45.274 | 37.223 | 69.992 | 49.455 | 41.105 | 75.773 | 43.203 | 45.929 | 34.648 | 67.358 | 34.973 | 46.525 | 35.427 |
Net Income Ratio
| -0.135 | 0.112 | 0.106 | 0.038 | 0.118 | 0.079 | 0.005 | 0.056 | 0.088 | 0.066 | 0.1 | 0.076 | 0.066 | 0.147 | 0.112 | 0.11 | 0.087 | 0.21 | 0.376 | 0.489 | 0.397 |
EPS
| -0.16 | 0.15 | 0.11 | 0.032 | 0.11 | 0.095 | 0.006 | 0.063 | 0.085 | 0.07 | 0.13 | 0.093 | 0.078 | 0.12 | 0.06 | 0.067 | 0.051 | 0.099 | 0.1 | 0.14 | 0.27 |
EPS Diluted
| -0.16 | 0.15 | 0.11 | 0.032 | 0.11 | 0.095 | 0.006 | 0.063 | 0.085 | 0.07 | 0.13 | 0.093 | 0.078 | 0.12 | 0.06 | 0.067 | 0.051 | 0.099 | 0.1 | 0.14 | 0.27 |
EBITDA
| -7.203 | 128.254 | -10.292 | 50.146 | 100.534 | 90.199 | 42.238 | 69.342 | 86.663 | 81.598 | 120.335 | 93.754 | 87.531 | 112.844 | 80.033 | 82.298 | 67.863 | 91.609 | 45.982 | 58.478 | 41 |
EBITDA Ratio
| -0.011 | 0.176 | -0.019 | 0.113 | 0.203 | 0.141 | 0.067 | 0.117 | 0.168 | 0.145 | 0.171 | 0.144 | 0.141 | 0.219 | 0.208 | 0.197 | 0.171 | 0.285 | 0.494 | 0.614 | 0.459 |